nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—MTOR—obesity	0.327	0.847	CbGaD
Tacrolimus—ORM1—Bupropion—obesity	0.0997	0.353	CbGbCtD
Tacrolimus—ALB—obesity	0.0589	0.153	CbGaD
Tacrolimus—CYP3A7-CYP3A51P—Cimetidine—obesity	0.033	0.117	CbGbCtD
Tacrolimus—CYP3A7—Cimetidine—obesity	0.033	0.117	CbGbCtD
Tacrolimus—CYP3A5—Cimetidine—obesity	0.0247	0.0877	CbGbCtD
Tacrolimus—CYP3A4—Sibutramine—obesity	0.0204	0.0723	CbGbCtD
Tacrolimus—ABCB1—Cimetidine—obesity	0.0161	0.0571	CbGbCtD
Tacrolimus—CYP3A4—Benzphetamine—obesity	0.0155	0.0548	CbGbCtD
Tacrolimus—CYP3A4—Bupropion—obesity	0.0131	0.0466	CbGbCtD
Tacrolimus—CYP3A4—Orlistat—obesity	0.0107	0.038	CbGbCtD
Tacrolimus—CYP3A4—Cimetidine—obesity	0.00965	0.0342	CbGbCtD
Tacrolimus—CYP3A4—Topiramate—obesity	0.00632	0.0224	CbGbCtD
Tacrolimus—ORM1—bile—obesity	0.00453	0.0868	CbGeAlD
Tacrolimus—PPP3CA—hindbrain—obesity	0.00245	0.047	CbGeAlD
Tacrolimus—ABCA5—islet of Langerhans—obesity	0.00235	0.045	CbGeAlD
Tacrolimus—ABCA5—adrenal cortex—obesity	0.00186	0.0356	CbGeAlD
Tacrolimus—MTOR—hindbrain—obesity	0.00181	0.0347	CbGeAlD
Tacrolimus—PPP3CA—islet of Langerhans—obesity	0.00158	0.0304	CbGeAlD
Tacrolimus—ABCA5—pituitary gland—obesity	0.0015	0.0288	CbGeAlD
Tacrolimus—PPP3CA—respiratory system—obesity	0.0015	0.0287	CbGeAlD
Tacrolimus—ABCA5—adipose tissue—obesity	0.0015	0.0287	CbGeAlD
Tacrolimus—ABCA5—adrenal gland—obesity	0.00134	0.0257	CbGeAlD
Tacrolimus—Everolimus—MTOR—obesity	0.00128	0.306	CrCbGaD
Tacrolimus—Pimecrolimus—MTOR—obesity	0.00128	0.306	CrCbGaD
Tacrolimus—ORM1—gall bladder—obesity	0.00126	0.0241	CbGeAlD
Tacrolimus—PPP3CA—adrenal cortex—obesity	0.00126	0.0241	CbGeAlD
Tacrolimus—ABCA5—endocrine gland—obesity	0.00116	0.0223	CbGeAlD
Tacrolimus—PPP3CA—cardiovascular system—obesity	0.00115	0.022	CbGeAlD
Tacrolimus—MTOR—respiratory system—obesity	0.00111	0.0212	CbGeAlD
Tacrolimus—ALB—gall bladder—obesity	0.0011	0.0211	CbGeAlD
Tacrolimus—ABCA5—liver—obesity	0.00105	0.0201	CbGeAlD
Tacrolimus—PPP3CA—pituitary gland—obesity	0.00101	0.0194	CbGeAlD
Tacrolimus—PPP3CA—adipose tissue—obesity	0.00101	0.0194	CbGeAlD
Tacrolimus—FKBP1A—respiratory system—obesity	0.000994	0.0191	CbGeAlD
Tacrolimus—PPP3CA—digestive system—obesity	0.000951	0.0182	CbGeAlD
Tacrolimus—PPP3CA—adrenal gland—obesity	0.000907	0.0174	CbGeAlD
Tacrolimus—Temsirolimus—MTOR—obesity	0.000865	0.207	CrCbGaD
Tacrolimus—MTOR—cardiovascular system—obesity	0.000847	0.0162	CbGeAlD
Tacrolimus—FKBP1A—adrenal cortex—obesity	0.000834	0.016	CbGeAlD
Tacrolimus—PPP3CA—endocrine gland—obesity	0.000786	0.0151	CbGeAlD
Tacrolimus—Sirolimus—MTOR—obesity	0.000762	0.182	CrCbGaD
Tacrolimus—FKBP1A—cardiovascular system—obesity	0.000761	0.0146	CbGeAlD
Tacrolimus—MTOR—pituitary gland—obesity	0.00075	0.0144	CbGeAlD
Tacrolimus—MTOR—adipose tissue—obesity	0.000747	0.0143	CbGeAlD
Tacrolimus—PPP3CA—liver—obesity	0.000709	0.0136	CbGeAlD
Tacrolimus—MTOR—digestive system—obesity	0.000703	0.0135	CbGeAlD
Tacrolimus—FKBP1A—pituitary gland—obesity	0.000674	0.0129	CbGeAlD
Tacrolimus—FKBP1A—adipose tissue—obesity	0.000671	0.0129	CbGeAlD
Tacrolimus—MTOR—adrenal gland—obesity	0.00067	0.0128	CbGeAlD
Tacrolimus—CYP3A7—endocrine gland—obesity	0.000646	0.0124	CbGeAlD
Tacrolimus—FKBP1A—digestive system—obesity	0.000632	0.0121	CbGeAlD
Tacrolimus—FKBP1A—adrenal gland—obesity	0.000602	0.0115	CbGeAlD
Tacrolimus—CYP3A7—liver—obesity	0.000583	0.0112	CbGeAlD
Tacrolimus—MTOR—endocrine gland—obesity	0.000581	0.0111	CbGeAlD
Tacrolimus—MTOR—liver—obesity	0.000524	0.01	CbGeAlD
Tacrolimus—FKBP1A—endocrine gland—obesity	0.000522	0.01	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—liver—obesity	0.000495	0.00949	CbGeAlD
Tacrolimus—FKBP1A—liver—obesity	0.000471	0.00902	CbGeAlD
Tacrolimus—CYP3A5—islet of Langerhans—obesity	0.000458	0.00879	CbGeAlD
Tacrolimus—CYP3A5—respiratory system—obesity	0.000433	0.0083	CbGeAlD
Tacrolimus—ALB—adrenal gland—obesity	0.000413	0.00792	CbGeAlD
Tacrolimus—ORM1—endocrine gland—obesity	0.000409	0.00784	CbGeAlD
Tacrolimus—ORM1—liver—obesity	0.000369	0.00706	CbGeAlD
Tacrolimus—ALB—liver—obesity	0.000323	0.00619	CbGeAlD
Tacrolimus—CYP3A5—adipose tissue—obesity	0.000292	0.0056	CbGeAlD
Tacrolimus—CYP3A5—digestive system—obesity	0.000275	0.00527	CbGeAlD
Tacrolimus—ABCB1—islet of Langerhans—obesity	0.000244	0.00467	CbGeAlD
Tacrolimus—ABCB1—respiratory system—obesity	0.00023	0.00441	CbGeAlD
Tacrolimus—CYP3A5—endocrine gland—obesity	0.000227	0.00436	CbGeAlD
Tacrolimus—CYP3A4—digestive system—obesity	0.000207	0.00396	CbGeAlD
Tacrolimus—CYP3A5—liver—obesity	0.000205	0.00393	CbGeAlD
Tacrolimus—ABCB1—adrenal cortex—obesity	0.000193	0.0037	CbGeAlD
Tacrolimus—ABCB1—cardiovascular system—obesity	0.000176	0.00338	CbGeAlD
Tacrolimus—CYP3A4—endocrine gland—obesity	0.000171	0.00327	CbGeAlD
Tacrolimus—ABCB1—pituitary gland—obesity	0.000156	0.00299	CbGeAlD
Tacrolimus—ABCB1—adipose tissue—obesity	0.000155	0.00298	CbGeAlD
Tacrolimus—CYP3A4—liver—obesity	0.000154	0.00295	CbGeAlD
Tacrolimus—ABCB1—digestive system—obesity	0.000146	0.0028	CbGeAlD
Tacrolimus—ABCB1—adrenal gland—obesity	0.000139	0.00267	CbGeAlD
Tacrolimus—ABCB1—endocrine gland—obesity	0.000121	0.00232	CbGeAlD
Tacrolimus—ABCB1—liver—obesity	0.000109	0.00209	CbGeAlD
Tacrolimus—Orthostatic hypotension—Topiramate—obesity	6.8e-05	0.0004	CcSEcCtD
Tacrolimus—Discomfort—Sibutramine—obesity	6.79e-05	0.000399	CcSEcCtD
Tacrolimus—Hypokalaemia—Topiramate—obesity	6.78e-05	0.000398	CcSEcCtD
Tacrolimus—Muscle spasms—Bupropion—obesity	6.77e-05	0.000398	CcSEcCtD
Tacrolimus—Infection—Orlistat—obesity	6.76e-05	0.000398	CcSEcCtD
Tacrolimus—Breast disorder—Topiramate—obesity	6.73e-05	0.000395	CcSEcCtD
Tacrolimus—Dry mouth—Sibutramine—obesity	6.72e-05	0.000395	CcSEcCtD
Tacrolimus—Toxic epidermal necrolysis—Topiramate—obesity	6.71e-05	0.000394	CcSEcCtD
Tacrolimus—Nervous system disorder—Orlistat—obesity	6.68e-05	0.000392	CcSEcCtD
Tacrolimus—Confusional state—Sibutramine—obesity	6.64e-05	0.00039	CcSEcCtD
Tacrolimus—Vision blurred—Bupropion—obesity	6.63e-05	0.00039	CcSEcCtD
Tacrolimus—Skin disorder—Orlistat—obesity	6.61e-05	0.000389	CcSEcCtD
Tacrolimus—Tremor—Bupropion—obesity	6.59e-05	0.000388	CcSEcCtD
Tacrolimus—Gastritis—Topiramate—obesity	6.59e-05	0.000387	CcSEcCtD
Tacrolimus—Anaphylactic shock—Sibutramine—obesity	6.59e-05	0.000387	CcSEcCtD
Tacrolimus—Oedema—Sibutramine—obesity	6.59e-05	0.000387	CcSEcCtD
Tacrolimus—Hyperhidrosis—Orlistat—obesity	6.58e-05	0.000387	CcSEcCtD
Tacrolimus—Muscular weakness—Topiramate—obesity	6.57e-05	0.000386	CcSEcCtD
Tacrolimus—Infection—Sibutramine—obesity	6.55e-05	0.000385	CcSEcCtD
Tacrolimus—Ill-defined disorder—Bupropion—obesity	6.53e-05	0.000384	CcSEcCtD
Tacrolimus—Anaemia—Bupropion—obesity	6.51e-05	0.000382	CcSEcCtD
Tacrolimus—Shock—Sibutramine—obesity	6.48e-05	0.000381	CcSEcCtD
Tacrolimus—Abdominal distension—Topiramate—obesity	6.48e-05	0.000381	CcSEcCtD
Tacrolimus—Agitation—Bupropion—obesity	6.47e-05	0.00038	CcSEcCtD
Tacrolimus—Thrombocytopenia—Sibutramine—obesity	6.45e-05	0.000379	CcSEcCtD
Tacrolimus—Dysphagia—Topiramate—obesity	6.44e-05	0.000378	CcSEcCtD
Tacrolimus—Asthma—Topiramate—obesity	6.44e-05	0.000378	CcSEcCtD
Tacrolimus—Tachycardia—Sibutramine—obesity	6.43e-05	0.000378	CcSEcCtD
Tacrolimus—Skin disorder—Sibutramine—obesity	6.4e-05	0.000376	CcSEcCtD
Tacrolimus—Hyperhidrosis—Sibutramine—obesity	6.37e-05	0.000374	CcSEcCtD
Tacrolimus—Malaise—Bupropion—obesity	6.35e-05	0.000373	CcSEcCtD
Tacrolimus—Vertigo—Bupropion—obesity	6.32e-05	0.000372	CcSEcCtD
Tacrolimus—Syncope—Bupropion—obesity	6.31e-05	0.000371	CcSEcCtD
Tacrolimus—Pancreatitis—Topiramate—obesity	6.31e-05	0.000371	CcSEcCtD
Tacrolimus—Leukopenia—Bupropion—obesity	6.3e-05	0.00037	CcSEcCtD
Tacrolimus—Anorexia—Sibutramine—obesity	6.28e-05	0.000369	CcSEcCtD
Tacrolimus—Sweating increased—Topiramate—obesity	6.27e-05	0.000368	CcSEcCtD
Tacrolimus—Angina pectoris—Topiramate—obesity	6.27e-05	0.000368	CcSEcCtD
Tacrolimus—Palpitations—Bupropion—obesity	6.22e-05	0.000366	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Orlistat—obesity	6.2e-05	0.000365	CcSEcCtD
Tacrolimus—Bronchitis—Topiramate—obesity	6.19e-05	0.000364	CcSEcCtD
Tacrolimus—Loss of consciousness—Bupropion—obesity	6.19e-05	0.000364	CcSEcCtD
Tacrolimus—Insomnia—Orlistat—obesity	6.16e-05	0.000362	CcSEcCtD
Tacrolimus—Hypotension—Sibutramine—obesity	6.16e-05	0.000362	CcSEcCtD
Tacrolimus—Cough—Bupropion—obesity	6.14e-05	0.000361	CcSEcCtD
Tacrolimus—Paraesthesia—Orlistat—obesity	6.11e-05	0.000359	CcSEcCtD
Tacrolimus—Pancytopenia—Topiramate—obesity	6.11e-05	0.000359	CcSEcCtD
Tacrolimus—Convulsion—Bupropion—obesity	6.1e-05	0.000358	CcSEcCtD
Tacrolimus—Hypertension—Bupropion—obesity	6.08e-05	0.000357	CcSEcCtD
Tacrolimus—Dysuria—Topiramate—obesity	6.02e-05	0.000354	CcSEcCtD
Tacrolimus—Neutropenia—Topiramate—obesity	6.02e-05	0.000354	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Sibutramine—obesity	6e-05	0.000353	CcSEcCtD
Tacrolimus—Dyspepsia—Orlistat—obesity	5.99e-05	0.000352	CcSEcCtD
Tacrolimus—Chest pain—Bupropion—obesity	5.99e-05	0.000352	CcSEcCtD
Tacrolimus—Myalgia—Bupropion—obesity	5.99e-05	0.000352	CcSEcCtD
Tacrolimus—Arthralgia—Bupropion—obesity	5.99e-05	0.000352	CcSEcCtD
Tacrolimus—Anxiety—Bupropion—obesity	5.97e-05	0.000351	CcSEcCtD
Tacrolimus—Insomnia—Sibutramine—obesity	5.96e-05	0.00035	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	5.95e-05	0.00035	CcSEcCtD
Tacrolimus—Pollakiuria—Topiramate—obesity	5.95e-05	0.000349	CcSEcCtD
Tacrolimus—Discomfort—Bupropion—obesity	5.92e-05	0.000348	CcSEcCtD
Tacrolimus—Decreased appetite—Orlistat—obesity	5.92e-05	0.000348	CcSEcCtD
Tacrolimus—Paraesthesia—Sibutramine—obesity	5.92e-05	0.000348	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Orlistat—obesity	5.88e-05	0.000345	CcSEcCtD
Tacrolimus—Dyspnoea—Sibutramine—obesity	5.87e-05	0.000345	CcSEcCtD
Tacrolimus—Photosensitivity reaction—Topiramate—obesity	5.87e-05	0.000345	CcSEcCtD
Tacrolimus—Fatigue—Orlistat—obesity	5.87e-05	0.000345	CcSEcCtD
Tacrolimus—Dry mouth—Bupropion—obesity	5.86e-05	0.000344	CcSEcCtD
Tacrolimus—Somnolence—Sibutramine—obesity	5.86e-05	0.000344	CcSEcCtD
Tacrolimus—Weight increased—Topiramate—obesity	5.86e-05	0.000344	CcSEcCtD
Tacrolimus—Weight decreased—Topiramate—obesity	5.82e-05	0.000342	CcSEcCtD
Tacrolimus—Pain—Orlistat—obesity	5.82e-05	0.000342	CcSEcCtD
Tacrolimus—Hyperglycaemia—Topiramate—obesity	5.81e-05	0.000341	CcSEcCtD
Tacrolimus—Dyspepsia—Sibutramine—obesity	5.8e-05	0.000341	CcSEcCtD
Tacrolimus—Confusional state—Bupropion—obesity	5.79e-05	0.00034	CcSEcCtD
Tacrolimus—Pneumonia—Topiramate—obesity	5.77e-05	0.000339	CcSEcCtD
Tacrolimus—Oedema—Bupropion—obesity	5.74e-05	0.000338	CcSEcCtD
Tacrolimus—Anaphylactic shock—Bupropion—obesity	5.74e-05	0.000338	CcSEcCtD
Tacrolimus—Infestation NOS—Topiramate—obesity	5.74e-05	0.000337	CcSEcCtD
Tacrolimus—Infestation—Topiramate—obesity	5.74e-05	0.000337	CcSEcCtD
Tacrolimus—Decreased appetite—Sibutramine—obesity	5.73e-05	0.000337	CcSEcCtD
Tacrolimus—Depression—Topiramate—obesity	5.72e-05	0.000336	CcSEcCtD
Tacrolimus—Infection—Bupropion—obesity	5.71e-05	0.000335	CcSEcCtD
Tacrolimus—Stevens-Johnson syndrome—Topiramate—obesity	5.69e-05	0.000334	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Sibutramine—obesity	5.69e-05	0.000334	CcSEcCtD
Tacrolimus—Shock—Bupropion—obesity	5.65e-05	0.000332	CcSEcCtD
Tacrolimus—Renal failure—Topiramate—obesity	5.64e-05	0.000332	CcSEcCtD
Tacrolimus—Pain—Sibutramine—obesity	5.64e-05	0.000331	CcSEcCtD
Tacrolimus—Constipation—Sibutramine—obesity	5.64e-05	0.000331	CcSEcCtD
Tacrolimus—Nervous system disorder—Bupropion—obesity	5.63e-05	0.000331	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Topiramate—obesity	5.63e-05	0.000331	CcSEcCtD
Tacrolimus—Thrombocytopenia—Bupropion—obesity	5.62e-05	0.000331	CcSEcCtD
Tacrolimus—Feeling abnormal—Orlistat—obesity	5.61e-05	0.00033	CcSEcCtD
Tacrolimus—Tachycardia—Bupropion—obesity	5.61e-05	0.000329	CcSEcCtD
Tacrolimus—Stomatitis—Topiramate—obesity	5.59e-05	0.000329	CcSEcCtD
Tacrolimus—Skin disorder—Bupropion—obesity	5.58e-05	0.000328	CcSEcCtD
Tacrolimus—Conjunctivitis—Topiramate—obesity	5.58e-05	0.000328	CcSEcCtD
Tacrolimus—Urinary tract infection—Topiramate—obesity	5.58e-05	0.000328	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Orlistat—obesity	5.57e-05	0.000327	CcSEcCtD
Tacrolimus—Hyperhidrosis—Bupropion—obesity	5.55e-05	0.000326	CcSEcCtD
Tacrolimus—Anorexia—Bupropion—obesity	5.48e-05	0.000322	CcSEcCtD
Tacrolimus—Haematuria—Topiramate—obesity	5.47e-05	0.000322	CcSEcCtD
Tacrolimus—Feeling abnormal—Sibutramine—obesity	5.43e-05	0.000319	CcSEcCtD
Tacrolimus—Epistaxis—Topiramate—obesity	5.41e-05	0.000318	CcSEcCtD
Tacrolimus—Urticaria—Orlistat—obesity	5.41e-05	0.000318	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Sibutramine—obesity	5.39e-05	0.000317	CcSEcCtD
Tacrolimus—Sinusitis—Topiramate—obesity	5.38e-05	0.000316	CcSEcCtD
Tacrolimus—Abdominal pain—Orlistat—obesity	5.38e-05	0.000316	CcSEcCtD
Tacrolimus—Body temperature increased—Orlistat—obesity	5.38e-05	0.000316	CcSEcCtD
Tacrolimus—Hypotension—Bupropion—obesity	5.37e-05	0.000315	CcSEcCtD
Tacrolimus—Agranulocytosis—Topiramate—obesity	5.36e-05	0.000315	CcSEcCtD
Tacrolimus—Bradycardia—Topiramate—obesity	5.24e-05	0.000308	CcSEcCtD
Tacrolimus—Urticaria—Sibutramine—obesity	5.23e-05	0.000308	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Bupropion—obesity	5.23e-05	0.000308	CcSEcCtD
Tacrolimus—Body temperature increased—Sibutramine—obesity	5.21e-05	0.000306	CcSEcCtD
Tacrolimus—Abdominal pain—Sibutramine—obesity	5.21e-05	0.000306	CcSEcCtD
Tacrolimus—Insomnia—Bupropion—obesity	5.2e-05	0.000305	CcSEcCtD
Tacrolimus—Haemoglobin—Topiramate—obesity	5.18e-05	0.000304	CcSEcCtD
Tacrolimus—Rhinitis—Topiramate—obesity	5.16e-05	0.000304	CcSEcCtD
Tacrolimus—Paraesthesia—Bupropion—obesity	5.16e-05	0.000303	CcSEcCtD
Tacrolimus—Hepatitis—Topiramate—obesity	5.15e-05	0.000303	CcSEcCtD
Tacrolimus—Haemorrhage—Topiramate—obesity	5.15e-05	0.000303	CcSEcCtD
Tacrolimus—Hallucination—Topiramate—obesity	5.13e-05	0.000301	CcSEcCtD
Tacrolimus—Hypoaesthesia—Topiramate—obesity	5.13e-05	0.000301	CcSEcCtD
Tacrolimus—Dyspnoea—Bupropion—obesity	5.12e-05	0.000301	CcSEcCtD
Tacrolimus—Pharyngitis—Topiramate—obesity	5.11e-05	0.0003	CcSEcCtD
Tacrolimus—Somnolence—Bupropion—obesity	5.11e-05	0.0003	CcSEcCtD
Tacrolimus—Urinary tract disorder—Topiramate—obesity	5.09e-05	0.000299	CcSEcCtD
Tacrolimus—Oedema peripheral—Topiramate—obesity	5.07e-05	0.000298	CcSEcCtD
Tacrolimus—Connective tissue disorder—Topiramate—obesity	5.06e-05	0.000298	CcSEcCtD
Tacrolimus—Dyspepsia—Bupropion—obesity	5.06e-05	0.000297	CcSEcCtD
Tacrolimus—Urethral disorder—Topiramate—obesity	5.05e-05	0.000297	CcSEcCtD
Tacrolimus—Hypersensitivity—Orlistat—obesity	5.02e-05	0.000295	CcSEcCtD
Tacrolimus—Decreased appetite—Bupropion—obesity	4.99e-05	0.000293	CcSEcCtD
Tacrolimus—Visual impairment—Topiramate—obesity	4.96e-05	0.000292	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Bupropion—obesity	4.96e-05	0.000291	CcSEcCtD
Tacrolimus—Fatigue—Bupropion—obesity	4.95e-05	0.000291	CcSEcCtD
Tacrolimus—Pain—Bupropion—obesity	4.91e-05	0.000289	CcSEcCtD
Tacrolimus—Constipation—Bupropion—obesity	4.91e-05	0.000289	CcSEcCtD
Tacrolimus—Asthenia—Orlistat—obesity	4.89e-05	0.000287	CcSEcCtD
Tacrolimus—Erythema multiforme—Topiramate—obesity	4.87e-05	0.000286	CcSEcCtD
Tacrolimus—Hypersensitivity—Sibutramine—obesity	4.85e-05	0.000285	CcSEcCtD
Tacrolimus—Pruritus—Orlistat—obesity	4.82e-05	0.000283	CcSEcCtD
Tacrolimus—Eye disorder—Topiramate—obesity	4.81e-05	0.000283	CcSEcCtD
Tacrolimus—Tinnitus—Topiramate—obesity	4.8e-05	0.000282	CcSEcCtD
Tacrolimus—Flushing—Topiramate—obesity	4.78e-05	0.000281	CcSEcCtD
Tacrolimus—Cardiac disorder—Topiramate—obesity	4.78e-05	0.000281	CcSEcCtD
Tacrolimus—Feeling abnormal—Bupropion—obesity	4.73e-05	0.000278	CcSEcCtD
Tacrolimus—Asthenia—Sibutramine—obesity	4.73e-05	0.000278	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Bupropion—obesity	4.7e-05	0.000276	CcSEcCtD
Tacrolimus—Angiopathy—Topiramate—obesity	4.67e-05	0.000275	CcSEcCtD
Tacrolimus—Pruritus—Sibutramine—obesity	4.66e-05	0.000274	CcSEcCtD
Tacrolimus—Diarrhoea—Orlistat—obesity	4.66e-05	0.000274	CcSEcCtD
Tacrolimus—Immune system disorder—Topiramate—obesity	4.65e-05	0.000273	CcSEcCtD
Tacrolimus—Mediastinal disorder—Topiramate—obesity	4.64e-05	0.000273	CcSEcCtD
Tacrolimus—Chills—Topiramate—obesity	4.62e-05	0.000272	CcSEcCtD
Tacrolimus—Urticaria—Bupropion—obesity	4.56e-05	0.000268	CcSEcCtD
Tacrolimus—Alopecia—Topiramate—obesity	4.55e-05	0.000268	CcSEcCtD
Tacrolimus—Abdominal pain—Bupropion—obesity	4.54e-05	0.000267	CcSEcCtD
Tacrolimus—Body temperature increased—Bupropion—obesity	4.54e-05	0.000267	CcSEcCtD
Tacrolimus—Mental disorder—Topiramate—obesity	4.51e-05	0.000265	CcSEcCtD
Tacrolimus—Diarrhoea—Sibutramine—obesity	4.51e-05	0.000265	CcSEcCtD
Tacrolimus—Dizziness—Orlistat—obesity	4.5e-05	0.000265	CcSEcCtD
Tacrolimus—Erythema—Topiramate—obesity	4.48e-05	0.000264	CcSEcCtD
Tacrolimus—Malnutrition—Topiramate—obesity	4.48e-05	0.000264	CcSEcCtD
Tacrolimus—Flatulence—Topiramate—obesity	4.42e-05	0.00026	CcSEcCtD
Tacrolimus—Tension—Topiramate—obesity	4.4e-05	0.000259	CcSEcCtD
Tacrolimus—Dysgeusia—Topiramate—obesity	4.39e-05	0.000258	CcSEcCtD
Tacrolimus—Dizziness—Sibutramine—obesity	4.36e-05	0.000256	CcSEcCtD
Tacrolimus—Nervousness—Topiramate—obesity	4.36e-05	0.000256	CcSEcCtD
Tacrolimus—Back pain—Topiramate—obesity	4.34e-05	0.000255	CcSEcCtD
Tacrolimus—Vomiting—Orlistat—obesity	4.33e-05	0.000254	CcSEcCtD
Tacrolimus—Muscle spasms—Topiramate—obesity	4.31e-05	0.000253	CcSEcCtD
Tacrolimus—Rash—Orlistat—obesity	4.29e-05	0.000252	CcSEcCtD
Tacrolimus—Dermatitis—Orlistat—obesity	4.29e-05	0.000252	CcSEcCtD
Tacrolimus—Headache—Orlistat—obesity	4.27e-05	0.000251	CcSEcCtD
Tacrolimus—Hypersensitivity—Bupropion—obesity	4.23e-05	0.000249	CcSEcCtD
Tacrolimus—Vision blurred—Topiramate—obesity	4.23e-05	0.000248	CcSEcCtD
Tacrolimus—Tremor—Topiramate—obesity	4.2e-05	0.000247	CcSEcCtD
Tacrolimus—Vomiting—Sibutramine—obesity	4.19e-05	0.000246	CcSEcCtD
Tacrolimus—Ill-defined disorder—Topiramate—obesity	4.16e-05	0.000245	CcSEcCtD
Tacrolimus—Rash—Sibutramine—obesity	4.15e-05	0.000244	CcSEcCtD
Tacrolimus—Dermatitis—Sibutramine—obesity	4.15e-05	0.000244	CcSEcCtD
Tacrolimus—Anaemia—Topiramate—obesity	4.14e-05	0.000244	CcSEcCtD
Tacrolimus—Headache—Sibutramine—obesity	4.13e-05	0.000243	CcSEcCtD
Tacrolimus—Asthenia—Bupropion—obesity	4.12e-05	0.000242	CcSEcCtD
Tacrolimus—Agitation—Topiramate—obesity	4.12e-05	0.000242	CcSEcCtD
Tacrolimus—Pruritus—Bupropion—obesity	4.06e-05	0.000239	CcSEcCtD
Tacrolimus—Nausea—Orlistat—obesity	4.04e-05	0.000238	CcSEcCtD
Tacrolimus—Malaise—Topiramate—obesity	4.04e-05	0.000238	CcSEcCtD
Tacrolimus—Vertigo—Topiramate—obesity	4.03e-05	0.000237	CcSEcCtD
Tacrolimus—Syncope—Topiramate—obesity	4.02e-05	0.000236	CcSEcCtD
Tacrolimus—Leukopenia—Topiramate—obesity	4.01e-05	0.000236	CcSEcCtD
Tacrolimus—Palpitations—Topiramate—obesity	3.96e-05	0.000233	CcSEcCtD
Tacrolimus—Loss of consciousness—Topiramate—obesity	3.94e-05	0.000232	CcSEcCtD
Tacrolimus—Diarrhoea—Bupropion—obesity	3.93e-05	0.000231	CcSEcCtD
Tacrolimus—Nausea—Sibutramine—obesity	3.91e-05	0.00023	CcSEcCtD
Tacrolimus—Cough—Topiramate—obesity	3.91e-05	0.00023	CcSEcCtD
Tacrolimus—Convulsion—Topiramate—obesity	3.89e-05	0.000228	CcSEcCtD
Tacrolimus—Hypertension—Topiramate—obesity	3.87e-05	0.000228	CcSEcCtD
Tacrolimus—Chest pain—Topiramate—obesity	3.82e-05	0.000224	CcSEcCtD
Tacrolimus—Arthralgia—Topiramate—obesity	3.82e-05	0.000224	CcSEcCtD
Tacrolimus—Myalgia—Topiramate—obesity	3.82e-05	0.000224	CcSEcCtD
Tacrolimus—Anxiety—Topiramate—obesity	3.8e-05	0.000224	CcSEcCtD
Tacrolimus—Dizziness—Bupropion—obesity	3.8e-05	0.000223	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	3.79e-05	0.000223	CcSEcCtD
Tacrolimus—Discomfort—Topiramate—obesity	3.77e-05	0.000222	CcSEcCtD
Tacrolimus—Dry mouth—Topiramate—obesity	3.73e-05	0.000219	CcSEcCtD
Tacrolimus—Confusional state—Topiramate—obesity	3.69e-05	0.000217	CcSEcCtD
Tacrolimus—Oedema—Topiramate—obesity	3.66e-05	0.000215	CcSEcCtD
Tacrolimus—Vomiting—Bupropion—obesity	3.65e-05	0.000215	CcSEcCtD
Tacrolimus—Infection—Topiramate—obesity	3.64e-05	0.000214	CcSEcCtD
Tacrolimus—Rash—Bupropion—obesity	3.62e-05	0.000213	CcSEcCtD
Tacrolimus—Dermatitis—Bupropion—obesity	3.62e-05	0.000213	CcSEcCtD
Tacrolimus—Shock—Topiramate—obesity	3.6e-05	0.000212	CcSEcCtD
Tacrolimus—Headache—Bupropion—obesity	3.6e-05	0.000211	CcSEcCtD
Tacrolimus—Nervous system disorder—Topiramate—obesity	3.59e-05	0.000211	CcSEcCtD
Tacrolimus—Thrombocytopenia—Topiramate—obesity	3.58e-05	0.000211	CcSEcCtD
Tacrolimus—Tachycardia—Topiramate—obesity	3.57e-05	0.00021	CcSEcCtD
Tacrolimus—Skin disorder—Topiramate—obesity	3.56e-05	0.000209	CcSEcCtD
Tacrolimus—Hyperhidrosis—Topiramate—obesity	3.54e-05	0.000208	CcSEcCtD
Tacrolimus—Anorexia—Topiramate—obesity	3.49e-05	0.000205	CcSEcCtD
Tacrolimus—Hypotension—Topiramate—obesity	3.42e-05	0.000201	CcSEcCtD
Tacrolimus—Nausea—Bupropion—obesity	3.41e-05	0.000201	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Topiramate—obesity	3.33e-05	0.000196	CcSEcCtD
Tacrolimus—Insomnia—Topiramate—obesity	3.31e-05	0.000195	CcSEcCtD
Tacrolimus—Paraesthesia—Topiramate—obesity	3.29e-05	0.000193	CcSEcCtD
Tacrolimus—Dyspnoea—Topiramate—obesity	3.26e-05	0.000192	CcSEcCtD
Tacrolimus—Somnolence—Topiramate—obesity	3.25e-05	0.000191	CcSEcCtD
Tacrolimus—Dyspepsia—Topiramate—obesity	3.22e-05	0.000189	CcSEcCtD
Tacrolimus—Decreased appetite—Topiramate—obesity	3.18e-05	0.000187	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Topiramate—obesity	3.16e-05	0.000186	CcSEcCtD
Tacrolimus—Fatigue—Topiramate—obesity	3.16e-05	0.000185	CcSEcCtD
Tacrolimus—Pain—Topiramate—obesity	3.13e-05	0.000184	CcSEcCtD
Tacrolimus—Constipation—Topiramate—obesity	3.13e-05	0.000184	CcSEcCtD
Tacrolimus—Feeling abnormal—Topiramate—obesity	3.02e-05	0.000177	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Topiramate—obesity	2.99e-05	0.000176	CcSEcCtD
Tacrolimus—Urticaria—Topiramate—obesity	2.91e-05	0.000171	CcSEcCtD
Tacrolimus—Abdominal pain—Topiramate—obesity	2.89e-05	0.00017	CcSEcCtD
Tacrolimus—Body temperature increased—Topiramate—obesity	2.89e-05	0.00017	CcSEcCtD
Tacrolimus—Hypersensitivity—Topiramate—obesity	2.7e-05	0.000158	CcSEcCtD
Tacrolimus—Asthenia—Topiramate—obesity	2.63e-05	0.000154	CcSEcCtD
Tacrolimus—Pruritus—Topiramate—obesity	2.59e-05	0.000152	CcSEcCtD
Tacrolimus—Diarrhoea—Topiramate—obesity	2.5e-05	0.000147	CcSEcCtD
Tacrolimus—Dizziness—Topiramate—obesity	2.42e-05	0.000142	CcSEcCtD
Tacrolimus—Vomiting—Topiramate—obesity	2.33e-05	0.000137	CcSEcCtD
Tacrolimus—Rash—Topiramate—obesity	2.31e-05	0.000136	CcSEcCtD
Tacrolimus—Dermatitis—Topiramate—obesity	2.31e-05	0.000135	CcSEcCtD
Tacrolimus—Headache—Topiramate—obesity	2.29e-05	0.000135	CcSEcCtD
Tacrolimus—Nausea—Topiramate—obesity	2.17e-05	0.000128	CcSEcCtD
Tacrolimus—FKBP1A—Disease—IL6—obesity	3.51e-06	3.34e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKR1C3—obesity	3.5e-06	3.33e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—obesity	3.5e-06	3.32e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRKCB—obesity	3.49e-06	3.32e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—F2—obesity	3.49e-06	3.32e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2E1—obesity	3.49e-06	3.32e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CAV1—obesity	3.46e-06	3.29e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOA1—obesity	3.45e-06	3.29e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—BAD—obesity	3.45e-06	3.28e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NQO1—obesity	3.45e-06	3.28e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SCARB1—obesity	3.44e-06	3.27e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—UCP2—obesity	3.4e-06	3.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HSD11B1—obesity	3.4e-06	3.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—UCP3—obesity	3.4e-06	3.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ECHS1—obesity	3.4e-06	3.23e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—AKT1—obesity	3.39e-06	3.22e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.38e-06	3.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—COMT—obesity	3.36e-06	3.19e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK8—obesity	3.35e-06	3.18e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.35e-06	3.18e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ADH1B—obesity	3.34e-06	3.18e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SREBF1—obesity	3.34e-06	3.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CG—obesity	3.34e-06	3.18e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARGC1A—obesity	3.31e-06	3.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GNB3—obesity	3.31e-06	3.15e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GCG—obesity	3.31e-06	3.15e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC2A4—obesity	3.31e-06	3.15e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IRS1—obesity	3.3e-06	3.14e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HMOX1—obesity	3.3e-06	3.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARGC1B—obesity	3.29e-06	3.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPAM—obesity	3.29e-06	3.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ACSL1—obesity	3.29e-06	3.13e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MYC—obesity	3.27e-06	3.11e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYCS—obesity	3.26e-06	3.11e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—obesity	3.26e-06	3.1e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GOT2—obesity	3.25e-06	3.09e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—AKT1—obesity	3.25e-06	3.09e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—AKT1—obesity	3.24e-06	3.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GNAS—obesity	3.22e-06	3.07e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GGT1—obesity	3.2e-06	3.05e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GOT1—obesity	3.2e-06	3.05e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HADH—obesity	3.2e-06	3.04e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PCK1—obesity	3.2e-06	3.04e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—FADS1—obesity	3.2e-06	3.04e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—obesity	3.19e-06	3.03e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—FASN—obesity	3.18e-06	3.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—POMC—obesity	3.18e-06	3.03e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—obesity	3.17e-06	3.01e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—BCHE—obesity	3.17e-06	3.01e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—INS—obesity	3.16e-06	3.01e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOB—obesity	3.16e-06	3e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NCOA1—obesity	3.16e-06	3e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CG—obesity	3.15e-06	3e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL2—obesity	3.11e-06	2.96e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—STK11—obesity	3.11e-06	2.96e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP19A1—obesity	3.11e-06	2.96e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ACP5—obesity	3.11e-06	2.96e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—STAT3—obesity	3.06e-06	2.91e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1—obesity	3.06e-06	2.91e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKT2—obesity	3.06e-06	2.91e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2E1—obesity	3.06e-06	2.91e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPARG—obesity	3.04e-06	2.9e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—G6PD—obesity	3.03e-06	2.88e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NQO1—obesity	3.02e-06	2.88e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—LPL—obesity	3.01e-06	2.87e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—POMC—obesity	3e-06	2.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HK1—obesity	2.99e-06	2.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SREBF2—obesity	2.99e-06	2.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—INS—obesity	2.99e-06	2.84e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GPX1—obesity	2.94e-06	2.8e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CD—obesity	2.94e-06	2.79e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AKT1—obesity	2.92e-06	2.78e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SERPINE1—obesity	2.91e-06	2.76e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GCG—obesity	2.9e-06	2.76e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC2A4—obesity	2.9e-06	2.76e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—COMT—obesity	2.89e-06	2.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LPA—obesity	2.89e-06	2.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CD36—obesity	2.86e-06	2.72e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYCS—obesity	2.86e-06	2.72e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARGC1A—obesity	2.85e-06	2.71e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GNB3—obesity	2.85e-06	2.71e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HMOX1—obesity	2.84e-06	2.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LPIN1—obesity	2.83e-06	2.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TYK2—obesity	2.83e-06	2.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—STAT3—obesity	2.83e-06	2.69e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GGT1—obesity	2.81e-06	2.67e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GOT1—obesity	2.81e-06	2.67e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RHOA—obesity	2.8e-06	2.67e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GNAS—obesity	2.78e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PIK3CA—obesity	2.78e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3R1—obesity	2.77e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOS3—obesity	2.77e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CD—obesity	2.77e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA5—obesity	2.77e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NCOA1—obesity	2.76e-06	2.63e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—obesity	2.74e-06	2.6e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—STK11—obesity	2.73e-06	2.59e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP19A1—obesity	2.73e-06	2.59e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOB—obesity	2.72e-06	2.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—obesity	2.71e-06	2.58e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARA—obesity	2.66e-06	2.53e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—obesity	2.66e-06	2.53e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CLOCK—obesity	2.64e-06	2.51e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC22A1—obesity	2.64e-06	2.51e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MYC—obesity	2.63e-06	2.5e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—obesity	2.62e-06	2.49e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3R1—obesity	2.62e-06	2.49e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NOS3—obesity	2.62e-06	2.49e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—LPL—obesity	2.6e-06	2.47e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AGT—obesity	2.58e-06	2.45e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SULT2A1—obesity	2.58e-06	2.45e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GLP1R—obesity	2.58e-06	2.45e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CB—obesity	2.56e-06	2.44e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DPYD—obesity	2.53e-06	2.41e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—COMT—obesity	2.53e-06	2.41e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GPX1—obesity	2.53e-06	2.41e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—obesity	2.53e-06	2.4e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CAV1—obesity	2.5e-06	2.38e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARGC1A—obesity	2.5e-06	2.38e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GNB3—obesity	2.5e-06	2.38e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOA1—obesity	2.5e-06	2.38e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HMOX1—obesity	2.49e-06	2.37e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CD36—obesity	2.47e-06	2.35e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—obesity	2.46e-06	2.34e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PRKAR2B—obesity	2.44e-06	2.32e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GNAS—obesity	2.43e-06	2.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DCN—obesity	2.42e-06	2.3e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CB—obesity	2.42e-06	2.3e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PIK3CA—obesity	2.41e-06	2.3e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—obesity	2.39e-06	2.28e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOB—obesity	2.38e-06	2.27e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CPT1A—obesity	2.36e-06	2.24e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—obesity	2.34e-06	2.22e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NAMPT—obesity	2.31e-06	2.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GCK—obesity	2.3e-06	2.18e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LIPC—obesity	2.3e-06	2.18e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARA—obesity	2.29e-06	2.18e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOC3—obesity	2.28e-06	2.17e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CG—obesity	2.28e-06	2.17e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LPL—obesity	2.27e-06	2.16e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AKT1—obesity	2.27e-06	2.16e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PIK3CA—obesity	2.26e-06	2.15e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PIK3CA—obesity	2.23e-06	2.12e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—obesity	2.23e-06	2.12e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AGT—obesity	2.22e-06	2.11e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GPX1—obesity	2.22e-06	2.11e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CETP—obesity	2.22e-06	2.11e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARG—obesity	2.2e-06	2.09e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SDC1—obesity	2.19e-06	2.08e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—obesity	2.18e-06	2.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—POMC—obesity	2.17e-06	2.06e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK8—obesity	2.16e-06	2.06e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CD36—obesity	2.16e-06	2.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—INS—obesity	2.16e-06	2.05e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CAV1—obesity	2.16e-06	2.05e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKR1C3—obesity	2.16e-06	2.05e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOA1—obesity	2.15e-06	2.05e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—obesity	2.14e-06	2.03e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SCARB1—obesity	2.12e-06	2.02e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.06e-06	1.96e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SREBF1—obesity	2.06e-06	1.96e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—obesity	2.05e-06	1.95e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARA—obesity	2.01e-06	1.91e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CD—obesity	2e-06	1.91e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GOT2—obesity	2e-06	1.91e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—STAT3—obesity	1.98e-06	1.88e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—obesity	1.98e-06	1.88e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—obesity	1.97e-06	1.88e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AKT1—obesity	1.97e-06	1.88e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CG—obesity	1.96e-06	1.87e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—FASN—obesity	1.96e-06	1.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—BCHE—obesity	1.95e-06	1.86e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AGT—obesity	1.95e-06	1.85e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—obesity	1.91e-06	1.81e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARG—obesity	1.9e-06	1.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NOS3—obesity	1.89e-06	1.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3R1—obesity	1.89e-06	1.8e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CAV1—obesity	1.89e-06	1.8e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOA1—obesity	1.88e-06	1.79e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2E1—obesity	1.88e-06	1.79e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—POMC—obesity	1.87e-06	1.78e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NQO1—obesity	1.86e-06	1.77e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—INS—obesity	1.86e-06	1.77e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—AKT1—obesity	1.85e-06	1.76e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MYC—obesity	1.84e-06	1.75e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—obesity	1.83e-06	1.74e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—AKT1—obesity	1.82e-06	1.73e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC2A4—obesity	1.79e-06	1.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GCG—obesity	1.79e-06	1.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYCS—obesity	1.76e-06	1.68e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CB—obesity	1.75e-06	1.66e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—obesity	1.73e-06	1.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GOT1—obesity	1.73e-06	1.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GGT1—obesity	1.73e-06	1.64e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CD—obesity	1.73e-06	1.64e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CG—obesity	1.72e-06	1.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NCOA1—obesity	1.7e-06	1.62e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP19A1—obesity	1.68e-06	1.6e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—STK11—obesity	1.68e-06	1.6e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARG—obesity	1.66e-06	1.58e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—POMC—obesity	1.64e-06	1.56e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3R1—obesity	1.63e-06	1.55e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NOS3—obesity	1.63e-06	1.55e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—INS—obesity	1.63e-06	1.55e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CA—obesity	1.56e-06	1.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—COMT—obesity	1.56e-06	1.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARGC1A—obesity	1.54e-06	1.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GNB3—obesity	1.54e-06	1.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HMOX1—obesity	1.53e-06	1.46e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CD—obesity	1.51e-06	1.44e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CB—obesity	1.5e-06	1.43e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GNAS—obesity	1.5e-06	1.43e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—obesity	1.49e-06	1.42e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—obesity	1.49e-06	1.42e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CA—obesity	1.47e-06	1.4e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOB—obesity	1.47e-06	1.4e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3R1—obesity	1.43e-06	1.36e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NOS3—obesity	1.43e-06	1.36e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LPL—obesity	1.4e-06	1.33e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—obesity	1.38e-06	1.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPX1—obesity	1.37e-06	1.3e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CD36—obesity	1.33e-06	1.27e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CB—obesity	1.32e-06	1.25e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—obesity	1.31e-06	1.24e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKT1—obesity	1.28e-06	1.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—obesity	1.26e-06	1.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARA—obesity	1.24e-06	1.18e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AKT1—obesity	1.2e-06	1.14e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AGT—obesity	1.2e-06	1.14e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—obesity	1.17e-06	1.12e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CAV1—obesity	1.16e-06	1.11e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA1—obesity	1.16e-06	1.1e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CA—obesity	1.07e-06	1.01e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CG—obesity	1.06e-06	1.01e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARG—obesity	1.02e-06	9.73e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—POMC—obesity	1.01e-06	9.6e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—INS—obesity	1e-06	9.54e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CD—obesity	9.32e-07	8.86e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—obesity	9.2e-07	8.75e-06	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CA—obesity	9.17e-07	8.72e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3R1—obesity	8.8e-07	8.37e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NOS3—obesity	8.8e-07	8.37e-06	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKT1—obesity	8.7e-07	8.27e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CB—obesity	8.12e-07	7.72e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—obesity	8.05e-07	7.65e-06	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CA—obesity	8.04e-07	7.64e-06	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKT1—obesity	7.49e-07	7.13e-06	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKT1—obesity	6.57e-07	6.24e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CA—obesity	4.95e-07	4.71e-06	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKT1—obesity	4.04e-07	3.85e-06	CbGpPWpGaD
